The Newsroom
Markets·October 13, 2026 at 1:44 PM EDT·1 source

J&J's 6% slide on an imperfect quarter is a gift to prospective buyers

JNJ -1.4%
JNJ · last 30 trading days+0.0% since the news
News

What happened

  • Johnson & Johnson shares fell 6% after what CNBC described as an imperfect quarter.
  • The company’s pharmaceutical division is performing strongly, while MedTech problems may be temporary.
  • CNBC characterized the share-price decline as an opportunity for prospective buyers.

Why it matters

The pullback may draw attention from prospective buyers and corporate-finance professionals, while healthcare investors assess whether MedTech weakness is temporary or structural.

Read more on YouBank

The Newsroom, ranked for your desk

About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.

Timeline

  1. EarlierOct 13
    J&J Leans Toward Ortho Spinoff as Medtech Sales Disappoint
  2. EarlierOct 13
    J&J Is Leaning Toward Spinning Out Its Hips-And-Knees Business
  3. EarlierOct 13
    Health Care Roundup: Market Talk
  4. First reported by CNBCOct 13
    J&J's 6% slide on an imperfect quarter is a gift to prospective buyers

Sources (1)

  1. CNBCOct 13
    J&J's 6% slide on an imperfect quarter is a gift to prospective buyers

Related

Read more on YouBank

The Newsroom, ranked for your desk

About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.

  • Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
  • Follow developing storiesAn alert, and a push, the moment a story you follow moves.
  • Your briefing, read aloudA few minutes each morning with a chapter per story.
  • Brief modeSwipe through the day, a 20-second card each.